Måndag 28 April | 13:08:02 Europe / Stockholm

2024-08-20 08:00:17

20 August 2024

Cambridge Cognition Holdings plc

("Cambridge Cognition", the "Company" or the "Group")

Notice of Results

Cambridge Cognition Holdings plc (AIM: COG), which develops and markets digital solutions to assess brain health, will announce its unaudited interim results for the six months ended 30 June 2024 on Thursday 22 August 2024.

Enquiries:

Cambridge Cognition Holdings plc  

Matthew Stork, Chief Executive Officer  

Tel: 012 2381 0700  

Panmure Liberum Limited (NOMAD and Joint Broker)  

Will Goode / Freddy Crossley / Mark Rogers   

Rupert Dearden  

Tel: 020 7886 2968  

(Corporate Finance)  

(Corporate Broking)  

Dowgate Capital Limited (Joint Broker)  

David Poutney / James Serjeant  

Tel: 020 3903 7715  

Hudson Sandler (Financial PR and IR)  

Dan de Belder / Hattie Dreyfus  

Tel: 020 7796 4133  

cog@hudsonsandler.com

Notes to Editors

About Cambridge Cognition

Cambridge Cognition is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The Company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.

For further information visit: https://cambridgecognition.com/